Literature DB >> 8516937

Historical development of brequinar sodium as a new immunosuppressive drug for transplantation.

L Makowka1, F Chapman, D V Cramer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8516937

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

2.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994

3.  A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

Authors:  R Shapiro; M Jordan; V Scantlebury; C Vivas; J Fung; J McCauley; A Tzakis; P Randhawa; A J Demetris; W Irish
Journal:  Clin Transplant       Date:  1994-12       Impact factor: 2.863

4.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

5.  FK506 in pediatric kidney transplantation--primary and rescue experience.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; A G Tzakis; D Ellis; N Gilboa; L Hopp; J McCauley; W Irish
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.